Inhibrx Announces Participation in Upcoming Scientific and Investor Conferences
/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and an emerging pre-clinical pipeline,...
Source: prnewswire.com